This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2002 Nov;72(5):595-6.

The efficacy of simvastatin is not influenced by CYP2D6 polymorphism

Jürgen Geisel, Kari T Kivistö, Ernst-Ulrich Griese, Michel Eichelbaum

PMID: 12426523

Comment

The efficacy of simvastatin is not influenced by CYP2D6 polymorphism

Jürgen Geisel et al. Clin Pharmacol Ther. 2002 Nov.

. 2002 Nov;72(5):595-6.

Authors

Jürgen Geisel, Kari T Kivistö, Ernst-Ulrich Griese, Michel Eichelbaum

PMID: 12426523

No abstract available

PubMed Disclaimer

Comment in

Response to "The efficacy of simvastatin is not influenced by CYP2D6 polymorphism" by Geisel et al.
Mulder AB, van den Bergh FA, Vermes I. Mulder AB, et al. Clin Pharmacol Ther. 2003 May;73(5):475. doi: 10.1016/s0009-9236(03)00054-7. Clin Pharmacol Ther. 2003. PMID: 12732847 No abstract available.

Comment on

Association of polymorphism in the cytochrome CYP2D6 and the efficacy and tolerability of simvastatin.
Mulder AB, van Lijf HJ, Bon MA, van den Bergh FA, Touw DJ, Neef C, Vermes I. Mulder AB, et al. Clin Pharmacol Ther. 2001 Dec;70(6):546-51. doi: 10.1067/mcp.2001.120251. Clin Pharmacol Ther. 2001. PMID: 11753271 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information